Sustained response to weekly vinblastine in 2 children with pilomyxoid astrocytoma associated with diencephalic syndrome

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 2, 2013, Pages

  Singh, Gurpreet ^a   Wei, Xing Chang ^a   Hader, Walter ^a   Chan, Jennifer A ^b   Bouffet, Eric ^c   Lafay Cousin, Lucie ^a  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

diencephalic syndrome; pilomyxoid astrocytoma; vinblastine

Indexed keywords

CARBOPLATIN; VINBLASTINE;

ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; BRAIN BIOPSY; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID SHUNTING; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; DIENCEPHALIC SYNDROME; DISEASE ASSOCIATION; DIVERGENT STRABISMUS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOMONYMOUS HEMIANOPIA; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE HYDROCEPHALUS; PILOMYXOID ASTROCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTROCYTOMA; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHALAMIC NEOPLASMS; INFANT; MALE; VINBLASTINE;

EID: 84874461514     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182707e67     Document Type: Article

References (17)

1. National Cancer Institute Available at: http://clinicaltrials.gov/show/ NCT00575796.
2. Burr IM, Slonim AE, Danish RK, et al. Diencephalic syndrome revisited. J Pediatr. 1976;883:439-444.
3. Tihan T, Fisher PG, Kepner JL, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol. 1999;58:1061-1106.
4. Komotar RJ, Burger PC, Carson BS, et al. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosur-gery. 2004;54:72-79; discussion 79-80.
5. Hamada H, Kurimoto M, Hayashi N, et al. Pilomyxoid astrocytoma in a patient presenting with fatal hemorrhage. Case report. J Neurosurg Pediatr. 2008;1:244-246.
6. Gropman AL, Packer RJ, Nicholson HS, et al. Treatment of dien-cephalic syndrome with chemotherapy. Cancer. 1998;83:166-172.
7. Zafeiriou DI, Koliouskas D, Vargiami E, et al. Russell's diencephalic syndrome. Neurology. 2001;57:932.
8. Nomura Y, Yasumoto S, Yanai F, et al. Survival and late effects on development of patients with infantile brain tumor. Pediatr Int. 2009;51:337-341.
9. Perilongo G, Carollo C, Salviati L, et al. Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region. Cancer. 1997;80: 142-146.
10. Von Hornstein S, Kortmann RD, Pietsch T, et al. Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 Trial. Pediatr Blood Cancer. 2011;56:1046-1054.
11. Sawamura Y, Kamoshima Y, Kato T, et al. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children. Jpn J Clin Oncol. 2009;39:277-283.
12. Fleischman A, Brue C, Poussaint TY, et al. Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics. 2005;115:e742-e748.
13. Lafay-Cousin L, Holm S, Qaddoumi I, et al. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer. 2005;103:2636-2642.
14. Bouffet E, Jakacki R, Goldman S, et al. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012;30:1358-1363.
15. Massimino M, Spreafico F, Cefalo G, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol. 2002;20:4209-4216.
16. Tsugu H, Oshiro S, Yanai F, et al. Management of pilomyxoid astrocytomas: our experience. Anticancer Res. 2009;29:919-926.
17. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 2003;21:1074-1081.